ARCHIVES

FDA Approves Abraxane And Alimta for NSCLC

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Caterpillar In. Benefits Plan To Cover Entry On BMT trials

June 14, 1996

Abstracts Of “Most Newsworthy” Papers At AACR Meeting

May 27, 1977

Drasga, Einhorn Make Appeal For Single-Payer Healthcare

January 31, 2014

NCI Cooperative Group Clinical Trials Approved

September 25, 2009

Interview: Von Eschenbach Says His Goal Is to Speed Development of Interventions

March 29, 2002

Obituaries: Paul Carbone; John Eisenberg; Paul Grotzinger

March 15, 2002